Sonoma Pharmaceuticals (SNOA) EPS (Basic): 2011-2012
Historic EPS (Basic) for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -$0.27.
- Sonoma Pharmaceuticals' EPS (Basic) rose 44.44% to -$0.05 in Q4 2012 from the same period last year, while for Dec 2012 it was -$0.18, marking a year-over-year increase of 30.77%. This contributed to the annual value of -$0.27 for FY2012, which is 10.00% up from last year.
- Latest data reveals that Sonoma Pharmaceuticals reported EPS (Basic) of -$0.27 as of FY2012, which was up 10.00% from -$0.30 recorded in FY2011.
- Over the past 5 years, Sonoma Pharmaceuticals' EPS (Basic) peaked at -$0.27 during FY2012, and registered a low of -$0.30 during FY2011.
- Its 2-year average for EPS (Basic) is -$0.29, with a median of -$0.29 in 2011.
- Data for Sonoma Pharmaceuticals' EPS (Basic) shows a peak YoY grew of 10.00% (in 2012) over the last 5 years.
- Yearly analysis of 2 years shows Sonoma Pharmaceuticals' EPS (Basic) stood at -$0.30 in 2011, then rose by 10.00% to -$0.27 in 2012.